Ethics Subcommittee, Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), 57363 [E8-23268]
Download as PDF
57363
Federal Register / Vol. 73, No. 192 / Thursday, October 2, 2008 / Notices
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
Form name
Risk manager questionnaire ............................................................
Total ..........................................................................................
Total burden
hours
1,020
1,020
Average hourly
wage rate1
425
425
Total cost burden
$27.10
(2)
$11,518
$11,518
1 Based upon the mean of the average wages, National Compensation Survey: Occupational wages in the United States 2006, ‘‘U.S. Department of Labor, Bureau of Labor Statistics.’’
2 Not applicable.
Estimated Annual Costs to the Federal
Government
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The Agency is supporting the conduct
of this survey and analysis of survey
data as part of a contract with the RAND
Corporation under which RAND serves
as the Patient Safety Evaluation Center
for AHRQ’s patient safety initiative. The
estimated cost for this work is $240,000,
including $190,000 for data collection
activities and $50,000 to design the
study, analyze the data and report the
findings.
Centers for Disease Control and
Prevention
Request for Comments
mstockstill on PROD1PC66 with NOTICES
In accordance with the above-cited
Paperwork Reduction Act legislation,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
AHRQ health care research, quality
improvement and information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: September 19, 2008.
Carolyn M. Clancy,
Director.
[FR Doc. E8–23370 Filed 10–1–08; 8:45 am]
BILLING CODE 4160–90–M
VerDate Aug<31>2005
17:52 Oct 01, 2008
Jkt 217001
Ethics Subcommittee, Advisory
Committee to the Director (ACD),
Centers for Disease Control and
Prevention (CDC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC announces the
following meeting for the
aforementioned subcommittee:
Name: Ethics Subcommittee, Advisory
Committee to the Director (ACD), CDC.
Time and Date: 12–2 p.m., October 9, 2008.
Place: This meeting will be held by
conference call. The call in number is (866)
919–3560 and enter passcode: 4168828.
Status: Open to the public. The public is
welcome to participate during the public
comment period which is tentatively
scheduled from 1:30 p.m.–1:45 p.m.
Purpose: The Ethics Subcommittee will
provide counsel to the ACD, CDC, regarding
a broad range of public health ethics
questions and issues arising from programs,
scientists and practitioners.
Matters to be Discussed: Agenda items will
include review of ethics guidance for public
health emergency preparedness and
response.
Contact Person for More Information: Drue
Barrett, PhD, Designated Federal Official,
Ethics Subcommittee, CDC, 1600 Clifton
Road, NE., M/S D–50, Atlanta, Georgia
30333. Telephone 404–639–4690, e-mail:
dbarrett@cdc.gov.
The Ethics Subcommittee determines that
subcommittee business requires its
consideration of this matter on less than 15
days notice to the public and that no earlier
notice of this meeting was possible. At the
Ethics Subcommittee’s September 25, 2008
meeting, the subcommittee discussed this
matter and determined that additional
consideration is necessary prior to submitting
the report to the ACD, CDC. The ACD, CDC
is scheduled to meet late October.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Dated: September 26, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–23268 Filed 10–1–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1419–N]
Medicare Program; Request for
Nominations for the Program Advisory
and Oversight Committee for the
Competitive Acquisition of Durable
Medical Equipment and Other Items
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice solicits
nominations for individuals to serve on
the Program Advisory and Oversight
Committee (PAOC) that will advise the
Secretary of Health and Human Services
on the competitive acquisition of
durable medical equipment and certain
other items and services under the
Medicare program. Section 1847(c) of
the Social Security Act requires the
Secretary of the Department of Health
and Human Services (Secretary) to
establish the PAOC. In addition, section
1847(c)(4) exempts the PAOC from the
Federal Advisory Committee Act, 5
U.S.C., appendix 2.
DATES: Nominations will be considered
if we receive all of the required
information no later than 5 p.m.,
November 3, 2008.
ADDRESSES: Mail or deliver nominations
to the following address: Division of
DMEPOS Policy, Mail stop C5–08–17,
Centers for Medicare & Medicaid
Services, 7500 Security Boulevard,
Baltimore MD, 21244–1850. Attention:
Ralph Goldberg or Gina Longus.
Nominations may also be e-mailed to
ralph.goldberg@cms.hhs.gov or
gina.longus@cms.hhs.gov.
E:\FR\FM\02OCN1.SGM
02OCN1
Agencies
[Federal Register Volume 73, Number 192 (Thursday, October 2, 2008)]
[Notices]
[Page 57363]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-23268]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Ethics Subcommittee, Advisory Committee to the Director (ACD),
Centers for Disease Control and Prevention (CDC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), CDC announces the following meeting for
the aforementioned subcommittee:
Name: Ethics Subcommittee, Advisory Committee to the Director
(ACD), CDC.
Time and Date: 12-2 p.m., October 9, 2008.
Place: This meeting will be held by conference call. The call in
number is (866) 919-3560 and enter passcode: 4168828.
Status: Open to the public. The public is welcome to participate
during the public comment period which is tentatively scheduled from
1:30 p.m.-1:45 p.m.
Purpose: The Ethics Subcommittee will provide counsel to the
ACD, CDC, regarding a broad range of public health ethics questions
and issues arising from programs, scientists and practitioners.
Matters to be Discussed: Agenda items will include review of
ethics guidance for public health emergency preparedness and
response.
Contact Person for More Information: Drue Barrett, PhD,
Designated Federal Official, Ethics Subcommittee, CDC, 1600 Clifton
Road, NE., M/S D-50, Atlanta, Georgia 30333. Telephone 404-639-4690,
e-mail: dbarrett@cdc.gov.
The Ethics Subcommittee determines that subcommittee business
requires its consideration of this matter on less than 15 days
notice to the public and that no earlier notice of this meeting was
possible. At the Ethics Subcommittee's September 25, 2008 meeting,
the subcommittee discussed this matter and determined that
additional consideration is necessary prior to submitting the report
to the ACD, CDC. The ACD, CDC is scheduled to meet late October.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: September 26, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-23268 Filed 10-1-08; 8:45 am]
BILLING CODE 4163-18-P